Agger Mette Kirstine 4
4 · scPharmaceuticals Inc. · Filed Jun 11, 2020
Insider Transaction Report
Form 4
Agger Mette Kirstine
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-09+6,124→ 6,124 totalExercise: $7.96Exp: 2030-06-09→ Common Stock (6,124 underlying)
Footnotes (1)
- [F1]This stock option vests in full upon the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders.